These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8785994

  • 1. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD.
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [Abstract] [Full Text] [Related]

  • 2. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K, Borrmann E, Werner E.
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [Abstract] [Full Text] [Related]

  • 3. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M.
    ALTEX; 2001 Apr; 18 Suppl 1():13-47. PubMed ID: 11854853
    [Abstract] [Full Text] [Related]

  • 4. Recommendations of the ECVAM Workshop on "Alternatives to Animal Testing in the Quality Control of Immunobiologicals; State of the Art and Future Prospects".
    Hendriksen CF.
    ALTEX; 1994 Apr; 11(5):19-20. PubMed ID: 11178401
    [Abstract] [Full Text] [Related]

  • 5. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C, Zänker S.
    Dev Biol Stand; 1996 Apr; 86():49-51. PubMed ID: 8785991
    [No Abstract] [Full Text] [Related]

  • 6. [The ZEBET database on alternative methods to animal experiments in the Internet--a concrete contribution to the protection of animals].
    Grune B, Herrmann S, Dörendahl A, Skolik S, Behnck-Knoblau S, Box R, Spielmann H.
    ALTEX; 2000 Apr; 17(3):127-33. PubMed ID: 11105194
    [Abstract] [Full Text] [Related]

  • 7. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF.
    ALTEX; 2006 Apr; 23(3):187-90. PubMed ID: 17086348
    [Abstract] [Full Text] [Related]

  • 8. Do we need a "Chair of alternative methods", and where?
    Wendel A.
    ALTEX; 2002 Apr; 19(2):64-8. PubMed ID: 12098011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A 4R concept for the safety testing of immunobiologicals.
    Cussler K.
    Dev Biol Stand; 1999 Apr; 101():121-6. PubMed ID: 10566784
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [Abstract] [Full Text] [Related]

  • 16. Implementation of three Rs alternatives in regulatory testing: possibilities and obstacles--the view of the validator.
    Halder M, Balls M.
    Dev Biol (Basel); 2002 Apr; 111():199-206. PubMed ID: 12678242
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.